logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Tucker, Simon
    Chief Commercial Officer born in October 1974
    Individual (3 offsprings)
    Officer
    icon of calendar 2022-07-01 ~ now
    OF - Director → CIF 0
  • 2
    Ferry, Melvin Jeremy, Mr.
    Vice President, Strategic Finance born in June 1982
    Individual (7 offsprings)
    Officer
    icon of calendar 2025-02-06 ~ now
    OF - Director → CIF 0
  • 3
    Ettery, Nicholas
    Vice President Uk&I born in February 1973
    Individual (2 offsprings)
    Officer
    icon of calendar 2024-02-23 ~ now
    OF - Director → CIF 0
  • 4
    GOLDSHIELD GROUP LIMITED - 2012-03-20
    GOLDSHIELD GROUP PLC - 2010-01-04
    GOLDSHIELD PHARMACEUTICALS (EUROPE) LIMITED - 1998-05-08
    GOLDCREST PHARMACEUTICALS (EUROPE) LIMITED - 1992-07-02
    SETBIT LIMITED - 1989-09-26
    icon of addressDashwood House, 69 Old Broad Street, London, United Kingdom
    Active Corporate (3 parents, 12 offsprings)
    Person with significant control
    icon of calendar 2022-07-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 13
  • 1
    Kapadia, Sandip
    Chief Financial Officer born in March 1970
    Individual
    Officer
    icon of calendar 2017-10-01 ~ 2021-03-26
    OF - Director → CIF 0
  • 2
    Sharpe, Stewart Charles
    Company Director born in July 1965
    Individual (2 offsprings)
    Officer
    icon of calendar 2017-10-01 ~ 2017-12-31
    OF - Director → CIF 0
  • 3
    Duncan, Barbara
    Chief Finance Officer born in December 1964
    Individual
    Officer
    icon of calendar 2015-09-24 ~ 2017-10-01
    OF - Director → CIF 0
  • 4
    Van Weperen, Willem Wouter
    Company Director born in November 1967
    Individual
    Officer
    icon of calendar 2021-10-04 ~ 2022-07-01
    OF - Director → CIF 0
  • 5
    Barcelo Sanchez, Francisco Javier
    Regional Vice President born in January 1965
    Individual
    Officer
    icon of calendar 2022-07-01 ~ 2024-12-31
    OF - Director → CIF 0
  • 6
    Notarianni, Giancarlo
    General Manager born in January 1973
    Individual
    Officer
    icon of calendar 2017-12-31 ~ 2024-02-23
    OF - Director → CIF 0
  • 7
    Venezia, Rocco
    Company Director born in September 1975
    Individual (1 offspring)
    Officer
    icon of calendar 2021-05-20 ~ 2022-07-01
    OF - Director → CIF 0
  • 8
    Kamath, Vikram Laxman
    Vice President Finance And Group Controller born in September 1977
    Individual (15 offsprings)
    Officer
    icon of calendar 2022-07-01 ~ 2025-02-06
    OF - Director → CIF 0
  • 9
    Stockwell, Caroline Amelia
    Company Director born in November 1966
    Individual (3 offsprings)
    Officer
    icon of calendar 2021-03-17 ~ 2021-10-29
    OF - Director → CIF 0
  • 10
    Hood, Daniel Carey Cazel
    Solicitor born in January 1973
    Individual (2 offsprings)
    Officer
    icon of calendar 2015-09-24 ~ 2018-05-09
    OF - Director → CIF 0
  • 11
    Gemellaro, Michael
    Company Director born in June 1974
    Individual
    Officer
    icon of calendar 2021-05-20 ~ 2022-07-01
    OF - Director → CIF 0
  • 12
    QUAYSHELFCO 231 LIMITED - 1988-10-17
    icon of addressOne, Glass Wharf, Bristol, United Kingdom
    Active Corporate (4 parents, 223 offsprings)
    Equity (Company account)
    2 GBP2024-04-30
    Officer
    2015-09-24 ~ 2022-07-01
    PE - Secretary → CIF 0
  • 13
    icon of address10, Hudson Yards, 37th Floor, New York, New York, United States
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ 2022-07-01
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

ADVANZ PHARMA UK AND IRELAND LIMITED

Previous name
INTERCEPT PHARMA UK & IRELAND LTD - 2022-08-23
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Turnover/Revenue
14,121,158 GBP2023-01-01 ~ 2023-12-31
12,207,278 GBP2022-01-01 ~ 2022-12-31
Cost of Sales
-410,708 GBP2023-01-01 ~ 2023-12-31
-5,373,753 GBP2022-01-01 ~ 2022-12-31
Gross Profit/Loss
13,710,450 GBP2023-01-01 ~ 2023-12-31
6,833,525 GBP2022-01-01 ~ 2022-12-31
Distribution Costs
-1,246,164 GBP2023-01-01 ~ 2023-12-31
-103,079 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-12,015,969 GBP2023-01-01 ~ 2023-12-31
-5,885,610 GBP2022-01-01 ~ 2022-12-31
Other operating income
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
448,317 GBP2023-01-01 ~ 2023-12-31
844,836 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Interest Payable/Similar Charges (Finance Costs)
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
448,317 GBP2023-01-01 ~ 2023-12-31
844,836 GBP2022-01-01 ~ 2022-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-29,417 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Called-up share capital not yet paid and not classified as a current asset
0 GBP2023-12-31
0 GBP2022-12-31
Intangible Assets
0 GBP2023-12-31
0 GBP2022-12-31
Property, Plant & Equipment
0 GBP2023-12-31
0 GBP2022-12-31
Fixed Assets - Investments
0 GBP2023-12-31
0 GBP2022-12-31
Fixed Assets
0 GBP2023-12-31
0 GBP2022-12-31
Total Inventories
322,863 GBP2023-12-31
153,176 GBP2022-12-31
Debtors
33,630,045 GBP2023-12-31
30,626,397 GBP2022-12-31
Cash at bank and in hand
1,830,868 GBP2023-12-31
6,847,604 GBP2022-12-31
Current assets - Investments
0 GBP2023-12-31
0 GBP2022-12-31
Current Assets
35,783,776 GBP2023-12-31
37,627,177 GBP2022-12-31
Net Current Assets/Liabilities
7,014,686 GBP2023-12-31
5,839,343 GBP2022-12-31
Total Assets Less Current Liabilities
7,014,686 GBP2023-12-31
5,839,343 GBP2022-12-31
Creditors
Amounts falling due after one year
0 GBP2023-12-31
0 GBP2022-12-31
Net Assets/Liabilities
5,112,557 GBP2023-12-31
4,693,657 GBP2022-12-31
Equity
Called up share capital
10 GBP2023-12-31
10 GBP2022-12-31
Share premium
4,729,992 GBP2023-12-31
4,729,992 GBP2022-12-31
Retained earnings (accumulated losses)
382,555 GBP2023-12-31
-36,345 GBP2022-12-31
Equity
5,112,557 GBP2023-12-31
4,693,657 GBP2022-12-31
Average Number of Employees
132023-01-01 ~ 2023-12-31
142022-01-01 ~ 2022-12-31
Other types of inventories not specified separately
322,863 GBP2023-12-31
153,176 GBP2022-12-31
Trade Debtors/Trade Receivables
4,933,695 GBP2023-12-31
5,092,718 GBP2022-12-31
Prepayments/Accrued Income
214,183 GBP2023-12-31
145,664 GBP2022-12-31
Other Debtors
28,482,167 GBP2023-12-31
25,388,015 GBP2022-12-31
Debtors
Amounts falling due after one year
0 GBP2023-12-31
0 GBP2022-12-31
Bank Borrowings/Overdrafts
Amounts falling due within one year
0 GBP2023-12-31
0 GBP2022-12-31
Finance Lease Liabilities - Total Present Value
Amounts falling due within one year
0 GBP2023-12-31
0 GBP2022-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
1,381,456 GBP2023-12-31
1,747,896 GBP2022-12-31
Taxation/Social Security Payable
Amounts falling due within one year
206,412 GBP2023-12-31
789,408 GBP2022-12-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
1,888,639 GBP2023-12-31
1,646,256 GBP2022-12-31
Other Creditors
Amounts falling due within one year
25,292,583 GBP2023-12-31
27,604,274 GBP2022-12-31
  • ADVANZ PHARMA UK AND IRELAND LIMITED
    Info
    INTERCEPT PHARMA UK & IRELAND LTD - 2022-08-23
    Registered number 09793586
    icon of addressDashwood House, 69 Old Broad Street, London EC2M 1QS
    Private Limited Company incorporated on 2015-09-24 (10 years). The company status is Active.
    The last date of confirmation statement was made at 2024-09-30
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.